Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)

NCT04410146 is registered in ClinicalTrials.gov with Balt USA as lead sponsor.

NCT NCT04410146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04410146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)
Lead sponsor
Balt USA
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2020
Completion date
May 23, 2024
Enrollment
319 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

subdural hematoma, chronic